Clots in the Brain Vein

Cerebral venous thrombosis is a high-miss cause of headache and stroke-like symptoms, especially in younger patients. The diagnosis hinges on venous neuroimaging rather than exam findings or routine labs, and early anticoagulation matters even when intracerebral hemorrhage is present.

Recognizing Cerebral Venous Thrombosis

• Headache with deficit: Headache plus any focal neurologic deficit should raise concern for CVT, a venous stroke syndrome that often masquerades as routine migraine or benign headache.
• Young stroke seizure pattern: Stroke-like symptoms in a young patient, or a stroke accompanied by seizure, are classic red flags because seizures occur in roughly 40% of CVT cases.
• Repeated severe headache visits: A negative noncontrast head CT does not settle the question when severe headache keeps bringing a patient back, since 30% to 60% of cases have a normal initial CT. We get into that imaging pivot in the episode.
• Estrogen exposure risk: Estrogen-containing oral contraceptives are the standout risk factor, increasing CVT risk about sixfold in the typical demographic of women of reproductive age.
• Raised ICP clues: Papilledema strongly supports the diagnosis when present, but its absence does not exclude CVT because exam findings are too insensitive to safely rule it out.

Diagnosis and Initial Management

• Venous imaging requirement: Definitive diagnosis is made with CT venography or MR venography, because routine head CT, lumbar puncture, and standard labs cannot reliably rule CVT in or out.
• CT venogram performance: CT venography is a practical ED test with about 95% sensitivity and specificity, while MR venography remains the gold standard when available.
• D dimer limitation: D-dimer is too inconsistent for exclusion, with reported sensitivity only in the low-80s to mid-90s and poor specificity on the other side.
• Anticoagulation despite hemorrhage: Anticoagulation is the mainstay of treatment, and intracerebral hemorrhage from CVT is not itself a contraindication to starting it.
• Preferred first line agent: Low-molecular-weight heparin is generally preferred up front, while thrombolytics and endovascular therapy have not shown routine benefit over standard anticoagulation.
• ICP rescue escalation: Patients with marked intracranial hypertension may need ICU-level care, and decompressive craniectomy remains the key rescue option when swelling becomes dangerous. We walk through where that escalation matters in the chapter.

References: 

1. Spadaro A, et al. Cerebral venous thrombosis: Diagnosis and management in the emergency department setting. Am J Emerg Med. 2021;47:24-29. PMID: 33765589
2. Heldner MR, et al. Prediction of cerebral venous thrombosis with a new clinical score and D-dimer levels. Neurology. 2020;95(7):e898-e909. PMID: 32576633
3. Idiculla PS, et al. Cerebral Venous Thrombosis: A Comprehensive Review. Eur Neurol. 2020;83(4):369-379. PMID: 32877892
4. Ulivi L, et al. Cerebral venous thrombosis: a practical guide. Pract Neurol. 2020;20(5):356-367. PMID: 32958591